Drugs / FMT-c Lactobacillus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03804736 | Nov 2016 → Jun 2018 | Clostridium difficile colitis | Autonomous University of Nuevo León | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT-c Lactobacillus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03804736 ↗ |
| Route | Oral | “FMT-c Lactobacillus (15 capsules every 12 h for 2 days)” NCT03804736 ↗ |